wow...just wow. $48 million for being a whistleblower is pretty nice though....
|Quoting sturmovik (Reply 4):|
There's a line in that article that says that the execs at Ranbaxy looked at the regulations as an obstacle to be gamed. I think that sums it up perfectly. Practically every company in India tends to do that domestically.
|Quoting Nimish (Reply 6):|
I was curious to know why the FDA did not immediately ban all Ranbaxy drugs in entirety?